Stock market update: Nifty Pharma subdued as Cadila, Lupin, Cipla suffer losses

INSUBCONTINENT EXCLUSIVE:
NEW DELHI: Losses in shares of Cadila Healthcare (down 2.42 per cent), Dr
Reddy's Laboratories (down 1.43 per cent), Lupin (down 0.78 per cent) and Cipla (down 0.13 per cent) were weighing on the pharma pack in
afternoon trade on Wednesday
The Nifty Pharma index was trading almost flat at 10,049 around 01:20 pm despite gains in shares of Biocon (up 0.74 per cent), Sun
Pharmaceutical Industries (up 0.61 per cent) and Aurobindo Pharma (up 0.59 per cent)
Shares of Piramal Enterprises (up 0.40 per cent), Glenmark Pharmaceuticals (up 0.29 per cent) and Divi's Laboratories (up 0.16 per cent)
too were in the green
Equity market was reflecting cautious mood ahead of August series FO expiry scheduled tomorrow amid mixed cues from other Asian
bourses. The Indian rupee touched its all-time low of 70.58 against the US dollar, hitting the risk appetite of investors
Benchmark NSE Nifty50 index was down 28.10 points at 11710.4, while the BSE Sensex was 71.97 points down at 38824.66
Among the 50 stocks in the Nifty index, 23 were trading in the green, while 27 were in the red
UPL, YES Bank, ONGC, State Bank of India and Mahindra Mahindra were among the top gainers, while Coal India, Eicher Motors, IndusInd Bank,
Dr
Reddy's Laboratories and HDFC Bank were among the top losers in the Nifty pack of stocks.